HRT Financial’s AB InBev BUD Stock Holding History

HRT Financial’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,500	Closed	-$672K	–	3845
2025 Q4	$672K	Buy	+10,500	New	+$652K	﹤0.01%	1952

Other funds holding BUD

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $31.7B AUM 20.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HRT Financial's BUD Position: Q1 2026 in Review

HRT Financial increased its AB InBev (BUD) stake by 20% in Q1 2026, buying an estimated $3.28M and bringing the position to 271,614 shares worth $18.8M. The position accounts for 0.05% of the portfolio, ranked #353.

HRT Financial first reported a position in BUD in Q2 2020 and has held it in 14 quarters since. 544 funds tracked by Wall St. Rank hold BUD as of Q1 2026.

HRT Financial held 271,614 shares of AB InBev worth $18.8M as of Q1 2026.
HRT Financial bought 45,389 AB InBev shares in Q1 2026, an estimated $3.28M.
AB InBev made up 0.05% of HRT Financial's portfolio in Q1 2026, its #353 holding.
HRT Financial first reported a position in AB InBev in Q2 2020 and has held it in 14 quarters since.
544 funds tracked by Wall St. Rank held AB InBev as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.